ORYZON Announces Last Patient Last Visit in its Phase IIb PORTICO Study for Borderline Personality Disorder (BPD)

Company on track to report top line data milestone in 1Q 2024A total of 210 participants have been recruitedMultiple primary endpoints include reduction in agitation and aggression and overall BPD...

Related Keywords

Nacional ,California ,United States ,Spain ,San Diego ,Barcelona ,Comunidad Autonoma De Cataluna ,Madrid ,Serbia ,Boston ,Massachusetts ,Bulgaria ,Germany ,Daniel Foley ,Patricia Cobo ,Michael Ropacki ,Carlos Buesa ,Ashleyr Robinson ,Data Monitoring Committee ,Globenewswire Inc ,Lifesci Advisors ,Last Patient Visit ,Borderline Personality Disorder ,Interim Analysis ,Chief Medical Officer ,Secondary Progressive ,Kabuki Syndrome ,Personality Disorder ,Spanish Comisi ,Sci Advisors ,